Gina Z. D’Amato

Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial

Jean‐Yves Blay, César Serrano, Michael C. Heinrich et al. · The Lancet Oncology · 2020 · 407 citations · Full text

Medicine, Oncology, Pharmacology +6

Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas

Sant P. Chawla, Arthur P. Staddon, Laurence H. Baker et al. · Journal of Clinical Oncology · 2011 · 247 citations · Full text

Medicine, Oncology, Pharmacology +16

Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors

Mrinal M. Gounder, Ravin Ratan, Thierry Alcindor et al. · New England Journal of Medicine · 2023 · 242 citations · Full text

Medicine, Oncology, Pharmacology +13

Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib

Katherine A. Janeway, Karen Albritton, Annick D. Van den Abbeele et al. · Pediatric Blood & Cancer · 2009 · 161 citations

Medicine, Oncology, Pharmacotherapy +16

Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor

Scott M. Schuetze, Vanessa Bolejack, Edwin Choy et al. · Cancer · 2016 · 132 citations · Full text

Medicine, Oncology, Chemotherapy +16